CClinicalTrials.gg
CompletedNCT05749562CTM biomecUpdated Mar 20, 2024

Effect of a Brace on the Adolescent Idiopathic Scoliosis Breathing

An observational study in Adolescent Idiopathic Scoliosis, sponsored by CHU de Reims. Completed at 1 site in France. Open to female participants aged 12 Years to 16 Years. Per ClinicalTrials.gov, last updated 2024-03-20.

Sponsored by CHU de Reims · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Cross-sectional
Enrollment
12
Ages
12 Years to 16 Years
Sex
Female
01

Study summary

This study intends to investigate the effect of bracing on respiratory function in the treatment of adolescent idiopathic scoliosis (AIS). In particular, it will look at the effect of the brace on respiratory function and 3D volume of the thoracic cage. An additional evaluation of the pressure forces of the brace, using a connected t-shirt, will be carried out. The investigators hypothesise that the brace will decrease the respiratory parameters and 3D volume of the thoracic cage, especially during deep breathing.

Read the detailed description

Scoliosis is a 3D deformity of the spine with curvatures occurring in the three planes of space.

The brace is widely used for adolescent idiopathic scoliosis. The Cheneau-Toulouse-Munster (CTM) brace is a rigid brace, classically indicated for thoracic and lumbar curves. However, scoliosis induces structural deformation of the rib cage. This can lead to changes in thoracic volume associated with a respiratory disorder, mainly restrictive. But the effect of bracing on pulmonary function currently remains unclear.

Few studies in the literature have looked at the impact of the brace on lung function. In those studies, the findings were based on Pulmonary Function Test (PFT) results only. In the CTM biomec study, the investigators propose to evaluate lung function by PFT associated with biplanar radiography using EOS® system, which allows 3D modelling of the rib cage. An additional evaluation of the pressure forces of the CTM brace, using a connected t-shirt, will be carried out to better understand the biomechanics of the brace. It will allow us to observe the stress surfaces on the thorax during the respiratory cycle and to compare them with the adaptation kinematics of the thoracic cage.

02

Conditions studied

  • Adolescent Idiopathic Scoliosis

Browse trials for

Keywords

  • Adolescent
  • Female
  • Biomechanical Phenomena
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 12 is below the median of 89 across 233 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

CHU de Reims is the lead sponsor of 267 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 16 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study will be conducted with patients treated for scoliosis in the Department of Pediatric Surgery, at the American Memorial Hospital, CHU Reims.

Inclusion criteria

  • Adolescent girls aged 12 to 16
  • With a right thoracic or thoraco-lumbar curvature (right and left)
  • With a Cobb angle between 20 and 40°.
  • Treated with a Cheneau-Toulouse-Munster brace for more than 1 month
  • With a duration of brace wearing of more than 12/24h
  • Affiliated to a social security system

Exclusion criteria

Exclusion Criteria:

  • Male gender
  • Having a secondary scoliosis (neuromuscular, syndromic, post-traumatic, congenital pathology)
  • Having a respiratory pathology prior to the diagnosis of scoliosis
  • Have a history of spinal surgery
  • Having already benefited from a brace treatment
05

Study design

Observational model
Case-crossover
Time perspective
Cross-sectional
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • Adolescent Idiopathic Scoliosis with right thoracic or thoraco-lumbar curvature

    Patients will be treated with a Cheneau-Toulouse-Munster (CTM) brace, with a wearing time of more than 12 hours/24h, for more than 1 month.

    Device: Cheneau-Toulouse-Munster brace

Interventions

  • DeviceCheneau-Toulouse-Munster brace

    Full length, orthogonal anteroposterior and lateral X-rays will be taken with the Cheneau-Toulouse-Munster brace.

06

What researchers measure

Primary outcomes

  1. Total Lung Capacity (TLC)

    change with and without the brace

    Time frame: 1 day

Secondary outcomes

  1. Forced expiratory volume in one second

    change with and without the brace

    Time frame: 1 day

07

Study locations

1 site
  • Chu Reims
    Reims, 51092, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05749562
Lead sponsor
CHU de Reims
Responsible party
Sponsor
First posted
Mar 1, 2023
Start date
Feb 17, 2023
Primary completion
Aug 24, 2023
Completion
Mar 19, 2024
Last update
Mar 20, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion